Search results
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis.
- About Acorda
Since 1995, Acorda has been working to make tomorrows...
- For Patients
For Patients - Acorda Therapeutics Biotechnology Company |...
- Products Research
Acorda develops neurological therapy products to help people...
- Investors
Acorda Therapeutics is a biotechnology company focused on...
- News Events
News Events - Acorda Therapeutics Biotechnology Company | MS...
- Careers
At Acorda, our job satisfaction is rooted in knowing that...
- Focus On Therapies
Focus On Therapies - Acorda Therapeutics Biotechnology...
- In the Community
In the Community - Acorda Therapeutics Biotechnology Company...
- About Acorda
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders.
Acorda Therapeutics is a biotechnology company that develops and commercializes therapies for neurological disorders such as MS, Parkinson's, SCI, stroke and epilepsy. Learn more about their pipeline programs, approved products and corporate culture.
Apr 9, 2024 · After years of struggling with hurdles such as generic competition and significantly lower-than-expected sales of its top meds, Acorda Therapeutics is hanging up the gloves with a $185 million...
- Zoey Becker
Find the latest Acorda Therapeutics, Inc. (ACORQ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Nov 13, 2023 · Acorda Therapeutics is a biotechnology company developing therapies for neurological disorders. Find the latest news, events, and financial updates for Acorda Therapeutics on its investor relations website.
Acorda is a biotechnology company that develops therapies for neurological disorders, such as MS and cardiovascular diseases. Learn about our mission, culture, partnerships, and grant program on our website.